Fiber-derived butyrate and the prevention of colon cancer

Chemistry and Biology

Volumn 4, Issue 11, 1997, Pages 783-789

  Hassig, Christian A ^a   Tong, Jeffrey K ^a   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031280071     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90111-3     Document Type: Note

References (48)

1. Hill, M.J. (1995). Mini-symposium: dietary fibre, butyrate and colorectal cancer. Eur. J. Cancer Prev. 4, 341-378.
2. Feng, P., Ge, L., Akyhani, N. & Liau, G. (1996). Sodium butyrate is a potent modulator of smooth muscle cell proliferation and gene expression. Cell.Prolif. 29, 231-241.
3. Hodin, R.A., Meng, S., Archer, S. & Tang, R. (1996). Cellular growth state differentially regulates enterocyte gene expression in butyratetreated HT-29 cells. Cell. Growth Differ. 7, 647-653.
4. Kruh, J. (1982). Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 42, 65-82.
5. Riggs, M.G., Whittaker, R.G., Neumann, J.R. & Ingram, V.M. (1977). n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268, 462-464.
6. Pazin, M.J. & Kadonaga, J.T. (1997). What's up and down with histone deacetylation and transcription. Cell 89, 325-328.
7. Loidl, P. (1994). Histone acetylation: facts and questions. Chromosome 103, 441-449.
8. Brownell, J.E. & Allis, C.D. (1996). Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6, 176-184.
9. Yoshida, M., Horinouchi, S. & Beppu, T. (1995). Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423-430.
10. Brosch, G., Ransom, R., Lechner, T., Walton, J.D. & Loidl, P. (1995). Inhibition of maize histone deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum. Plant Cell 7, 1941-1950.
11. Darkin Rattray, S.J., et al. & Schmatz, D.M. (1996). Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc. Natl Acad. Sci. USA. 93, 13143-13147.
12. Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S. & Beppu, T. (1993). Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268, 22429-22435.
13. Taunton, J., Hassig, C.A. & Schreiber, S.L. (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411.
14. Ogryzko, V.V., Hirai, T.H., Russanova, V.R., Barbie, D.A. & Howard, B.H. (1996). Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16, 5210-5218.
15. Hassig, C.A. & Schreiber, S.L. (1997). Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1, 300-308.
16. Wade, P.A. & Wolffe, A.P.(1997). Chromatin: histone acetyltransferases in control. Curr. Biol. 7, 82-84.
17. Tichonicky, L., Kruh, J. & Defer, N. (1990). Sodium butyrate inhibits c-myc and stimulates c-fos expression in all the steps of the cell-cycle in hepatoma tissue cultured cells. Biol. Cell 69, 65-67.
18. Souleimani, A. & Asselin, C. (1993). Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett. 326, 45-50.
19. Rabizadeh, E., Shaklai, M., Nudelman, A., Eisenbach, L. & Rephaeli, A. (1993). Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. FEBS Lett. 328, 225-229.
20. Nakano, K., et al., & Sakai, T. (1997). Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272, 22199-22206.
21. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A. & el Houseini, M.E. (1994). Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9, 3389-3396.
22. Hunter, T. & Pines, J. (1994). Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
23. Luo, Y., Hurwitz, J. & Massague, J. (1995). Cell-cycle inhibition by independent CDK and PCNA binding domains in p21 Cip1. Nature 375, 159-161.
24. Macleod, K.F., .et al., & Jacks, T. (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9, 935-944.
25. Datto, M.B., Li, Y., Panus, J.F., Howe, D.J., Xiong, Y. & Wang, X.F. (1995). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl Acad. Sci. USA 92, 5545-5549.
26. Liu, M., Iavarone, A. & Freedman, L.P. (1996). Transcriptional activation of the human p21 (WAF1/CIP1) gene by retinoic acid receptor: correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271, 31723-31728.
27. Liu, M., Lee, M.H., Cohen, M., Bommakanti, M. & Freedman, L.P. (1996). Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-153.
28. Ogryzko, V.V., Wong, P. & Howard, B.H. (1997). WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell. Biol. 17, 4877-4882.
29. Yan, H. & Newport, J. (1995). An analysis of the regulation of DNA synthesis by cdk2, Cip1, and licensing factor. J. Cell. Biol. 129, 1-15.
30. Guadagno, T.M. & Newport, J.W. (1996). Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 84, 73-82.
31. Wu, H., Wade, M., Krall, L, Grisham, J., Xiong, Y. & Van Dyke, T. (1996). Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev. 10, 245-260.
32. Yamada, K., Ohtsu, M., Sugano, M. & Kimura, G. (1992). Effects of butyrate on cell cycle progression and polyploidization of various types of mammalian cells. Biosci. Biotechnol. Biochem. 56, 1261-1265.
33. Noda, A., Ning, Y., Venable, S., Pereira-Smith, O. & Smith, J. (1994). Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98.
34. Sambucetti, L., Idler, D., Chamberlin, H., Kohn, N. & Cohen, D. (1997). The histone deacetylase inhibitor, trapoxin, induces p21/waf1 transcription. Proc. Amer. Assoc. Can. Res. 38, 347.
35. Van Lint, C., Emiliani, S., Ott, M. & Verdin, E. (1996). Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15, 1112-1120.
36. Yang, W.M., Inouye, C., Zeng, Y., Bearss, D. & Seto, E. (1996). Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl Acad. Sci. USA 93, 12845-12850.
37. Shi, Y., Lee, J.-S. & Galvin, K.M. (1997). Everything you ever wanted to know about Yin Yang 1. Biochem. Biophys. Acta. 1332, 49-66.
38. Guo, B., et al., & Stein, J.L. (1997). YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene. Proc. Natl Acad. Sci. USA 94, 121-126.
39. 3-and butyrate-inducible responses. Proc. Natl Acad. Sci. USA 90, 2984-2988.
40. Yeivin, A., Tang, D.C. & Taylor, M.W. (1992). Sodium butyrate selectively induces transcription of promoters adjacent to the MoMSV viral enhancer. Gene 116, 159-164.
41. Lee, J.S., et al., & Shi, Y. (1995). Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300 [published erratum appears in Genes Dev (1995) 9, 1948-1949]. Genes Dev. 9, 1188-1198.
42. Andrews, G.K. & Adamson, E.D. (1987). Butyrate selectively activates the metallothionein gene in teratocarcinoma cells and induces hypersensitivity to metal induction. Nuc. Acids Res. 15, 5461-5475.
43. Lellemand, F., Courilleau, D., Sabbah, M., Redeuilh, G. & Mester, J. (1996). Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem. Biophys. Res. Comm. 229, 163-169.
44. Souleimani, A. & Asselin, C. (1993). Regulation of c-fos expression by sodium butyrate in the human colon carcinoma cell line CACO-2. Biochem. Biophys. Res. Comm. 193, 330-336.
45. Gedrich, R.W. & Engel, D.A. (1995). Identification of a novel E1A response element in the mouse c-fos promoter. J. Virology 69, 2333-2230.
46. Chen, G., Cohen, D., Mickley, L.A., Fojo, A.T. & Sikic, B.I. (1997). Transcriptional repression and activation of the mdr1 gene in human sarcoma cells. Proc. Amer. Assoc. Cancer Res. 38, 442.
47. Morrow, C.S., Nakagawa, M., Goldsmith, M., Madden, M.J. & Cown, K.H. (1994). Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells. J. Biol. Chem. 269, 10739-10746.
48. Yu, C.-W. & Lin, L.-Y. (1995). Cloning and characterization of the 5′-flanking region of metallothionein-1 gene from Chinese hamster ovary cells. Biochem. Biophys. Acta. 1262, 150-154.